Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2011-03-01 (15 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PARIS (75014), Paris
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE CENTRALE D'ALESIA : revenue, balance sheet and financial ratios
PHARMACIE CENTRALE D'ALESIA is a French company
founded 15 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PARIS (75014),
this company of category PME
shows in 2024 a net income positive of 395 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE CENTRALE D'ALESIA (SIREN 530614510)
Indicator
2024
2023
2022
2020
2019
2018
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
394 775 €
367 005 €
551 971 €
167 671 €
244 087 €
212 165 €
228 000 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE CENTRALE D'ALESIA generates positive net income of 395 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 228 k€ -> 395 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
394 775 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 116%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 39%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
116.32%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
39.254%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE CENTRALE D'ALESIA
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2018
2019
2020
2022
2023
2024
Debt ratio
359.261
303.124
178.5
173.993
178.736
196.325
116.32
Financial autonomy
19.293
22.221
31.672
32.926
31.161
29.518
39.254
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
116.322024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average-9 pts over 3 years
In 2024, the debt ratio of PHARMACIE CENTRALE D'ALESIA (116.32) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
39.25%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+9 pts over 3 years
In 2024, the financial autonomy of PHARMACIE CENTRALE D'ALESIA (39.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 153.21. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
153.211
Liquidity indicators evolution PHARMACIE CENTRALE D'ALESIA
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2018
2019
2020
2022
2023
2024
Liquidity ratio
220.174
256.869
227.906
283.067
256.262
246.498
153.211
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
153.212024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average-32 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE CENTRALE D'ALESIA (153.21) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE CENTRALE D'ALESIA in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE CENTRALE D'ALESIA is estimated at
5 511 350 €
(range 3 838 017€ - 8 245 296€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
3838k€5511k€8245k€
5 511 350 €Range: 3 838 017€ - 8 245 296€
NAF 5 année 2024
Valuation method used
Net Income Multiple
394 775 €
×
14.0x
=5 511 351 €
Range: 3 838 018€ - 8 245 296€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE CENTRALE D'ALESIA with other companies in the same sector:
Frequently asked questions about PHARMACIE CENTRALE D'ALESIA
What is the revenue of PHARMACIE CENTRALE D'ALESIA ?
The revenue of PHARMACIE CENTRALE D'ALESIA is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE CENTRALE D'ALESIA profitable?
Yes, PHARMACIE CENTRALE D'ALESIA generated a net profit of 395 k€ in 2024.
Where is the headquarters of PHARMACIE CENTRALE D'ALESIA ?
The headquarters of PHARMACIE CENTRALE D'ALESIA is located in PARIS (75014), in the department Paris.
Where to find the tax return of PHARMACIE CENTRALE D'ALESIA ?
The tax return of PHARMACIE CENTRALE D'ALESIA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE CENTRALE D'ALESIA operate?
PHARMACIE CENTRALE D'ALESIA operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart